The ability to diagnose a tumor and monitor its progression and response to treatment without the need to obtain a tissue biopsy has been a long-standing goal of cancer management. This capability is now in hand thanks to the technology known as liquid biopsy, currently one of the most exciting sectors of the in vitro diagnostics market.
The term ‘liquid biopsy’ is used to refer to a noninvasive diagnostic test that can identify various types of cancer or other conditions by detecting biomarkers in fluid samples such...
Although the main target of efforts to develop liquid biopsy products up to now has been cancer, the technology also has other potential applications, such as prenatal diagnosis of chromosome...